Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1995-06-07
1999-11-30
Kumar, Shailendra
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514210, 514250, 514825, 514886, A01N 4300
Patent
active
059943416
ABSTRACT:
The present invention provides compositions comprising an anti-angiogenic factor, and a polymeric carrier. Representative examples of anti-angiogenic factors include Anti-Invasive Factor, Retinoic acids and derivatives thereof, and paclitaxel. Also provided are methods for embolizing blood vessels, and eliminating biliary, urethral, esophageal, and tracheal/bronchial obstructions.
REFERENCES:
patent: 4542025 (1985-09-01), Tice et al.
patent: 5039521 (1991-08-01), Bolton et al.
patent: 5061724 (1991-10-01), Gertner
patent: 5511563 (1996-04-01), Diamond
patent: 5529786 (1996-06-01), Moore
patent: 5530003 (1996-06-01), Yanagawa
patent: 5583153 (1996-12-01), Brahn
Asako et.al., Inflammation,(abstract only), 1992.
Houri et al., "Animal models in rheumatoid arthritis," Current Opinion in Rheumatology 7: 201-205, 1995.
Innocenti et al., "Plasma and Tissue Disposition of Paclitaxel (Taxol) After Intraperitoneal Administration in Mice," Drug Metabolism and Disposition 23(7): 713-717, 1995.
Koch et al., "Cytokines in Rheumatoid Arthritis," J. Investig. Med. 43: 28-38, 1995.
Monkkonen et al., "Studies of liposome formulations for intra-articular delivery of clodronate," Journal of Controlled Release 35: 145-154, 1995.
Brahn et al., "Regression of Collagen-Induced Arthritis with Taxol, a Microtubule Stabilizer," Arthritis and Rheumatism 37(6): 839-845, 1994.
Dahlberg et al., "Intraarticular Injections of Hyaluronan in Patients with Cartilage Abnormalities and Knee Pain: A One-Year Double-Blind, Pacebo-Controlled Study," Arthritis and Rheumatism 37: 521-528, 1994.
Eiseman et al., "Plasma pharmacokinetics and tissue distribution of paclitaxel in CD.sub.2 F.sub.1 mice," Cancer Chemother. Pharmacol. 34: 465-471, 1994.
Kohler and Goldspiel, "Paclitaxel (Taxol)," Pharmacotherapy 14(1): 3-34, 1994.
Kuhn. J., "Pharmacology and Pharmacokinetics of Paclitaxel," Annals oF Pharmacotherapy 28:S15-S17, 1994.
Menkes, C., "Intraarticular Treatment of Osteoarthritis and Guidelines to its Assessment," Journal of Rheumatology 21(suppl 41): 74-76, 1994.
Oliver et al., "Suppression of Collagen-Induced Arthritis Using an Angiogenesis Inhibitor, AGM-1470, and a Microtubule Stablizer, Taxol," Cellular Immunology 157: 291-299, 1994.
Sonnichsen and Relling, "Clinical Pharmacokinetics of Paclitaxel," Clin. Pharmacokinet. 27(4): 256-269, 1994.
Spencer and Faulds, "Paclitaxel. A Review of its Pharmacodynamic and Pharmacokinetic Properties and Therapeutic Potential in the Treatment of Cancer," Drugs 48(5): 794-847, 1994.
Walter, et al., "Interstitial Taxol Delivered from a Biodegradable Polymer Implant against Experimental Malignant Glioma," Cancer Research 54: 2207-2212, 1994.
Bissett and Kaye, "Taxol and Taxotere--Current Status and Future Prospects," Eur. J. Cancer 29A(9): 1228-1231, 1993.
Tang et al., "Regression of Collagen-Induced Arthritis with Taxol, A Microtubule Stabilizer," Arth. Rheum. 36 (suppl): S45, 1993 (Abstract #42).
Bartoli et al., "In vitro and in vivo antitumoral activity of free, and encapsulated taxol," J. Microencapsulation 7(2): 191-197, 1990.
Harris Jr., E., "Rheumatoid Arthritis. Pathophysiology and Implications for Therapy," The New England Journal of Medicine 322(18): 1277-1289, 1990.
Ingber et al., "Synthetic analogues of fumagillin that inhibit angiogenesis and supress tumour growth," Nature 348: 555-557, 1990.
Rowinsky et al., "Taxol: A Novel Investigational Antimicrotubule Agent," J. Natl. Cancer Inst. 82(15): 1247-1259, 1990.
Ratcliffe et al., "Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritis knee joints of rabbits," J. Pharm. Pharmacol. 39:290-295, 1987.
Hunneyball et al., "Intra-articular administration of drugs," Pharmacy International: 118-122, 1986.
Ratcliffe et al., "Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs," J. Pharm Pharmacol. 36: 431-436, 1984.
Arsenault A. Larry
Hunter William L.
Machan Lindsay S.
Angiogenesis Technologies, Inc.
Kumar Shailendra
LandOfFree
Anti-angiogenic Compositions and methods for the treatment of ar does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-angiogenic Compositions and methods for the treatment of ar, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-angiogenic Compositions and methods for the treatment of ar will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1672796